Granulocyte colony-stimulating factor-primed leukocyte transfusions in candida tropicalis fungemia in neutropenic patients

Haematologica. 1997 May-Jun;82(3):362-3.

Abstract

Optimal management of fungemia in neutropenic patients is still controversial. Several reports have already stressed the poor prognosis in invasive candidiasis (80% mortality in several reports). Therefore granulocyte transfusions would appear to be useful in the management of these infections. We report the use of rhG-CSF-primed granulocyte transfusions plus amphotericin B in two neutropenic patients who developed life-threatening systemic fungal infections. This approach was successful and both patients fully recovered from the infection.

Publication types

  • Case Reports

MeSH terms

  • Acute Disease
  • Adult
  • Amphotericin B / therapeutic use
  • Antifungal Agents / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Candidiasis / drug therapy
  • Candidiasis / etiology
  • Candidiasis / therapy*
  • Combined Modality Therapy
  • Cytarabine / administration & dosage
  • Cytarabine / adverse effects
  • Fungemia / drug therapy
  • Fungemia / etiology
  • Fungemia / therapy*
  • Granulocyte Colony-Stimulating Factor / administration & dosage
  • Granulocyte Colony-Stimulating Factor / pharmacology*
  • Hematopoiesis / drug effects*
  • Humans
  • Leukemia, Myeloid / complications
  • Leukemia, Myeloid / drug therapy
  • Leukocyte Transfusion*
  • Mitoxantrone / administration & dosage
  • Mitoxantrone / adverse effects
  • Neutropenia / chemically induced
  • Neutropenia / complications*
  • Recombinant Proteins / administration & dosage
  • Recombinant Proteins / pharmacology
  • Remission Induction
  • Treatment Outcome
  • Waldenstrom Macroglobulinemia / drug therapy

Substances

  • Antifungal Agents
  • Recombinant Proteins
  • Cytarabine
  • Granulocyte Colony-Stimulating Factor
  • Amphotericin B
  • Mitoxantrone